Originally designed for animal health, Fenbendazole 444 Mg is gaining recognition for its possible applications in human medicine. Known for treating parasitic infections, it acts by disrupting glucose uptake in targeted organisms. Speculative claims suggest it might have anti-cancer potential. However, robust clinical studies are lacking, and self-medication can lead to adverse effects. Expert consultation is necessary to evaluate its risks and benefits in human contexts.